Emerging Down Syndrome therapies in the different phases of clinical trials are- AEF0217, ACI-24.060, Donepezil HCl, Memantine, E2020, RG1662, ELND005, Florbetaben (BAY94-9172), CD101, and others ...

11. Down Syndrome Emerging Therapies 12. Down Syndrome Market Outlook 13. Country-Wise Down Syndrome Market Analysis (2020–2034) 14. Down Syndrome Market Access and Reimbursement of Therapies 15.

In Canada, "the average lifespan of someone with Down syndrome is about 60 years old," said Dr. Brian Skotko, senior author ...

The Valentine Brothers — one of whom has Down syndrome — have amassed more than 8 million followers on TikTok. In 2022, Sofia Jirau became the first Victoria’s Secret model with Down syndrome.

Sleep apnea, or difficulty breathing at night, is common among children with Down syndrome—affecting up to 80% compared to ...

Earlier this week, Mattel unveiled its first Barbie doll with Down syndrome. And McKeon, a Down syndrome advocate who has the genetic condition herself, helped make it happen.

Tevlin has Down syndrome, in which an individual is born with an extra copy of the 21st chromosome, leading to some cognitive and developmental disability. She wants to prove to the public that ...

Medicaid is the primary source of health coverage for individuals with Down syndrome, providing critical medical, long-term services, and home and community-based support. A 2023 study published ...

A growing pipeline of targeted therapies, such as AEF0217 and ACI-24.060, shows increasing pharmaceutical interest in addressing cognitive and neurological aspects of Down Syndrome, paving the way ...

A Mass General Brigham-led study of 29 children with Down syndrome, between ages 4 to 13, found that the hyoglossal nerve ...